Okogen

Phase 2

San Diego, United StatesFounded 2016okogen.com

Innovating the Pink Eye Treatment Landscape Leading candidate in Phase 2B for the treatment of Acute Infectious Conjunctivitis. Research & Development Enhancing Lives Through Better Vision Okogen is a clinical stage ophthalmic pharmaceutical company. Our lead product is in clinical trials as a “one stop shop” treatment for all forms of acute infectious conjunctivitis, including […]

Founded

2016

Focus

Small Molecules

About

Innovating the Pink Eye Treatment Landscape Leading candidate in Phase 2B for the treatment of Acute Infectious Conjunctivitis. Research & Development Enhancing Lives Through Better Vision Okogen is a clinical stage ophthalmic pharmaceutical company. Our lead product is in clinical trials as a “one stop shop” treatment for all forms of acute infectious conjunctivitis, including […]

Funding History

2

Total raised: $20M

Series A$15MUndisclosedMar 15, 2022

Seed$5MUndisclosedAug 15, 2020

Company Info

TypePrivate

Founded2016

LocationSan Diego, United States

StagePhase 2

Contact

Sectors

Small Molecule Drugs

SIMILAR COMPANIES

BASi Research Products

Pre-clinical · West Lafayette

Bay BioSciences

Pre-clinical · San Francisco

Pre-clinical · Cambridge

Pre-clinical · Memphis

Belcher Pharmaceuticals

Pre-clinical · Miami

Is this your company?

Claim your profile to update information, add pipeline data, and connect with investors.